Skip to search formSkip to main contentSkip to account menu

ado-trastuzumab emtansine

Known as: T-DM1 cpd, Trastuzumab emtansine, Trastuzumab-MCC-DM1 Immunoconjugate 
An antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: HER2-targeted therapies have improved survival for advanced HER2-positive breast cancers (BC), but none have been… 
2011
2011
An investigation was conducted on the microbial con tamination of some herbal products hawked in Ado-Ekiti metropolis. Eight… 
2010
2010
1016 Background: The antibody-drug conjugate T-DM1 has shown encouraging efficacy in two phase II studies (4258g and 4374g) for… 
2010
2010
Background: Aberrant activation of the PI3K pathway has been hypothesized to reduce the efficacy of trastuzumab-based therapy in… 
2005
2005
A talajokra vonatkozo informacioigeny az utobbi evtizedekben erőteljesen megnovekedett, nem csak az agrarium reszeről. Az… 
2004
2004
Bu arastirmanin amaci, yetersizligi olan cocuga sahip anne ve babalarin algiladiklari stres, sosyal destek ve yasam doyumlari… 
1994
1994
This study investigates the hypothesis that inhibition of nucleoside transport during hypothermic storage elevates tissue…